Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to 'Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation' [AUTREV 19-5 (2020) 102507].
Rubio-Rivas M, Corbella X, Guillén-Del-Castillo A, Tolosa Vilella C, Colunga Argüelles D, Argibay A, Vargas Hitos JA, Todolí Parra JA, González-Echávarri C, Ortego-Centeno N, Trapiella Martínez L, Rodríguez Carballeira M, Marín Ballvé A, Pla Salas X, Perales Fraile I, Chamorro AJ, Madroñero Vuelta AB, Freire M, Ruiz Muñoz M, González García A, Pons Martín Del Campo I, Sánchez García ME, Bernal Bello D, Espinosa G, García Hernández FJ, Sáez Comet L, Ríos Blanco JJ, Fernández de la Puebla Giménez RÁ, Sánchez Trigo S, Fonollosa Pla V, Simeón Aznar CP; RESCLE investigators; Autoimmune Diseases Study Group (GEAS). Rubio-Rivas M, et al. Autoimmun Rev. 2021 May;20(5):102793. doi: 10.1016/j.autrev.2021.102793. Epub 2021 Mar 22. Autoimmun Rev. 2021. PMID: 33766615 No abstract available.
Assessing the impact of long-term inhaled corticosteroid therapy on patients with COVID-19 and coexisting chronic lung disease: A multicenter retrospective cohort study.
Pina Belmonte A, Madrazo M, Piles L, Rubio-Rivas M, de Jorge Huerta L, Gómez Antúnez M, López Caleya JF, Arnalich Fernández F, Gericó-Aseguinolaza M, Pesqueira Fontan PM, Rhyman N, Prieto Dehesa M, Romero Cabrera JL, García García GM, García-Casasola G, Labirua-Iturburu Ruiz A, Carrasco-Sánchez FJ, Martínez Hernández S, Pascual Pérez MLR, López Castro J, Serrano Carrillo de Albornoz JL, Varona JF, Gómez-Huelgas R, Antón-Santos JM, Lumbreras-Bermejo C. Pina Belmonte A, et al. Among authors: rubio rivas m. Can J Respir Ther. 2024 Jun 5;60:86-94. doi: 10.29390/001c.118514. eCollection 2024. Can J Respir Ther. 2024. PMID: 38855380 Free PMC article.
Applying the ACR/EULAR Systemic Sclerosis Classification Criteria to the Spanish Scleroderma Registry Cohort.
Sáez-Comet L, Simeón-Aznar CP, Pérez-Conesa M, Vallejo-Rodríguez C, Tolosa-Vilella C, Iniesta-Arandia N, Colunga-Argüelles D, Egurbide-Arberas MV, Ortego-Centeno N, Vargas-Hitos JA, Freire-Dapena M, Rubio-Rivas M, Ríos-Blanco JJ, Trapiella-Martínez L, Fonollosa-Pla V; RESCLE Investigators. Sáez-Comet L, et al. J Rheumatol. 2015 Dec;42(12):2327-31. doi: 10.3899/jrheum.150144. Epub 2015 Oct 15. J Rheumatol. 2015. PMID: 26472418
Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry.
Tolosa-Vilella C, Morera-Morales ML, Simeón-Aznar CP, Marí-Alfonso B, Colunga-Arguelles D, Callejas Rubio JL, Rubio-Rivas M, Freire-Dapena M, Guillén-Del Castillo A, Iniesta-Arandia N, Castillo-Palma MJ, Egurbide-Arberas M, Trapiellla-Martínez L, Vargas-Hitos JA, Todolí-Parra JA, Rodriguez-Carballeira M, Marin-Ballvé A, Pla-Salas X, Rios-Blanco JJ, Fonollosa-Pla V; RESCLE Investigators, Autoimmune Diseases Study Group (GEAS). Tolosa-Vilella C, et al. Semin Arthritis Rheum. 2016 Oct;46(2):200-208. doi: 10.1016/j.semarthrit.2016.04.007. Epub 2016 May 18. Semin Arthritis Rheum. 2016. PMID: 27312381
Changes in the pattern of death of 987 patients with systemic sclerosis from 1990 to 2009 from the nationwide Spanish Scleroderma Registry (RESCLE).
Rubio-Rivas M, Simeón-Aznar CP, Velasco C, Marí-Alfonso B, Espinosa G, Corbella X, Colunga-Argüelles D, Egurbide-Arberas MV, Ortego-Centeno N, Vargas-Hitos JA, Freire M, Ríos-Blanco JJ, Trapiella-Martínez L, Rodríguez-Carballeira M, Fonollosa-Pla V; RESCLE investigators, Autoimmune Diseases Study Group (GEAS). Rubio-Rivas M, et al. Clin Exp Rheumatol. 2017 Sep-Oct;35 Suppl 106(4):40-47. Epub 2017 Feb 6. Clin Exp Rheumatol. 2017. PMID: 28229826
Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.
Trapiella-Martínez L, Díaz-López JB, Caminal-Montero L, Tolosa-Vilella C, Guillén-Del Castillo A, Colunga-Argüelles D, Rubio-Rivas M, Iniesta-Arandia N, Castillo-Palma MJ, Sáez-Comet L, Egurbide-Arberas MV, Ortego-Centeno N, Freire M, Vargas-Hitos JA, Ríos-Blanco JJ, Todolí-Parra JA, Rodríguez-Carballeira M, Marín-Ballvé A, Chamorro-Fernández AJ, Pla-Salas X, Madroñero-Vuelta AB, Ruiz-Muñóz M, Fonollosa-Pla V, Simeón-Aznar CP; RESCLE Investigators, on Behalf of the Autoimmune Diseases Study Group (GEAS), Spanish Society of Internal Medicine (SEMI). Trapiella-Martínez L, et al. Autoimmun Rev. 2017 Aug;16(8):796-802. doi: 10.1016/j.autrev.2017.05.013. Epub 2017 May 28. Autoimmun Rev. 2017. PMID: 28564618
118 results